FDA Rejects E-Cigarettes, Approves IQOS Tobacco Products

Jan.31.2023
FDA Rejects E-Cigarettes, Approves IQOS Tobacco Products
FDA rejects R.J. Reynolds' request to release flavored e-cigarettes, but authorizes sales of PMI's tobacco-flavored IQOS products.

Recently, the US Food and Drug Administration (FDA) has once again denied a request from tobacco giant R.J. Reynolds to bring two electronic cigarette products to the market. According to American health organizations, "existing evidence suggests that non-tobacco flavored electronic cigarettes pose a known substantial risk to young people; on the other hand, data shows that tobacco flavored electronic cigarettes do not have the same appeal to young people and therefore do not pose an equivalent level of risk.


A few days later, the FDA authorized PMI to sell three types of tobacco sticks for IQOS, known as Marlboro Sienna, Marlboro Bronze, and Marlboro Amber. They contain no additional flavors other than tobacco. Many observers are highly skeptical that the FDA will ever authorize any flavored products.


In 2020, approximately 34 million Americans continued to smoke. The scent of the flavors in e-cigarette liquids has been proven to be crucial in helping smokers quit.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South
Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South
Two global tobacco harm reduction experts, in their submission to 2Firsts, argue that several COP11 policy proposals driven by high-income countries do not align with the capacities and conditions of low- and middle-income countries. They highlight research and funding gaps and call for a more equitable global support mechanism.
Nov.19
NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
New York City has reached settlement agreements with two e-cigarette wholesalers accused of selling flavored vapes illegally. The companies agreed to stop all flavored vape transactions in the city and face $1,000 fines for future violations. Litigation against other defendants in the broader case continues.
Nov.25 by 2FIRSTS.ai
Malaysian state of Selangor proposes sharing e-cigarette tax revenue with federal government for local enforcement agencies
Malaysian state of Selangor proposes sharing e-cigarette tax revenue with federal government for local enforcement agencies
Selangor, Malaysia proposes federal government share e-cigarette tax revenues for local enforcement, suggesting collaboration for better regulation.
Oct.13 by 2FIRSTS.ai
EPO Invalidates Philip Morris Heated Tobacco Patent After Imperial Brands Challenge
EPO Invalidates Philip Morris Heated Tobacco Patent After Imperial Brands Challenge
The European Patent Office invalidated Philip Morris International’s heated tobacco patent, ruling it lacked inventiveness after a challenge by Imperial Brands’ subsidiary Fontem Ventures BV.
Oct.11 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Social media users reported purchasing Altria’s new nicotine pouch, on!PLUS, in the United States. 2Firsts found that the official on! website had temporarily opened online purchase and store locator functions. The product has not received FDA authorization. Around the same time, British American Tobacco (BAT) suspended its unlicensed Vuse One vape launch in the U.S. amid regulatory pressure.
Oct.28 by 2FIRSTS.ai